What’s New for 2023
Two Days of In-Depth Break Out Sessions
20 main conference sessions providing enhanced learning opportunities to deliver critical information on the topics most pressing to you.
Marquee Focus Sessions on Artificial Intelligence
Advanced, cutting-edge discussions on the product liability risks of AI usage in drug and device development, and the opportunities and perils of AI-assisted legal representation.
Spotlight on Proposed New Rule 16.1
Seasoned MDL practitioners will shed light on how newly proposed FRCP 16.1 will transform the future of MDL case management.
MDL Case Studies – 2023 Edition
An assessment of the year’s biggest and most complex MDLs: lessons learned from Tylenol, Zantac and Exactech.
Broadening Horizons: A Global Outlook on Drug & Device Product Liability Litigation
An exploration of critical international developments impacting drug and device product liability litigation in foreign jurisdictions.
400+
Attendees
20+
Revamped Panel Discussions
65+
Speakers
Including 25+ In-House Counsel from Industry Leading Companies
3
Days of Networking
Collaborate and network with your products liability defense peers from industry, private practice, and government.
Pre-Conference Workshops
Workshop AMDL Defense Strategy War Room: Developing a Tactical Tool-Kit for Managing Unique MDL Challenges and Combatting Meritless Claims
December 4, 2023
9:00 am – 12:30 pm
Workshop B3C’s Working Group: Advisory Board Edition Cost, Competency and Communication: Esteemed Members of the Drug and Med Advisory Board Speak on Their Expectations of Law Firm Partners With Regard to the “Three C’s”
December 4, 2023
1:30 – 5:00 pm
